GHK-Cu
- Category
- Skin & Cosmetic
- Administration routes
- InjectableTopical
- Regulatory status
- Not FDA-approved
What it is
The copper-bound form of the GHK tripeptide, marketed for skin rejuvenation, wound healing, hair growth, and tissue repair. The strongest cases, skin and wound healing, rest mostly on topical and lab studies with thin human data, while hair growth, neuroprotection, and DNA repair are speculative. Injectable research-grade supply is unregulated and of uncertain purity, and best avoided in Wilson disease and copper allergy. Not an approved drug in the US.
Read Full recordStudied uses & evidence
Studied uses(7)
Skin rejuvenation
MediumSmall human studies show collagen induction and reduced wrinkle volume, with mixed objective results.
Wound healing
MediumThe 64.5% versus 28.2% result came from rats. Human topical wound evidence is limited; post-laser objective outcomes were negative.
Anti-inflammatory/antioxidant
LowBoosts antioxidant enzymes and cuts lipid peroxidation, but evidence is largely lab-based.
Evidence limits
- Evidence Level
- Limited Clinical
Multiple placebo-controlled studies confirm wrinkle reduction, skin improvement. RCT (n=40): 55.8% wrinkle volume reduction. Finkley (n=67): improvements across all skin parameters. Miller RCT: no significant objective post-laser benefit; patient-reported satisfaction was higher. Human safety evidence is limited, particularly for injections.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
Do not use if
Wilson's disease
AbsoluteCopper accumulation disorder. Additional copper delivery is dangerous.
Copper sensitivity/allergy
HighContains copper. Can cause local reactions in sensitive individuals.
Active cancer
ModerateGHK-Cu stimulates blood vessel growth and cell proliferation, which may promote tumor growth.
Risk summary(5)
Risks = level of concern: High · Moderate · Low · Theoretical
Contraindicated in Wilson disease (genetic copper overload)
ModerateContraindicated in copper allergy
ModerateInsufficient safety data for pregnancy/breastfeeding
ModerateInjectable forms unregulated; quality risks
HighLong-term systemic effects of exogenous copper peptide not fully studied
Moderate
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.